苯
医学
绝对风险降低
队列
风险评估
队列研究
混淆
职业暴露
风险因素
环境卫生
内科学
置信区间
化学
计算机安全
计算机科学
有机化学
作者
Roel Vermeulen,Lützen Portengen,Guilan Li,Ethel S. Gilbert,Graça M. Dores,Bu‐Tian Ji,Richard B. Hayes,Sognian Yin,Nathaniel Rothman,Martha S. Linet,Qing Lan
出处
期刊:Occupational and Environmental Medicine
[BMJ]
日期:2022-03-10
卷期号:79 (9): 610-617
被引量:5
标识
DOI:10.1136/oemed-2021-108155
摘要
Benzene is a known haematoxin and leukemogen that can cause benzene poisoning (BP), that is, a persistent reduction in white cell counts that is strongly associated with increased risk of lymphohaematopoietic malignancies. Data are needed on the exposure-response, particularly at low doses and susceptible populations for clinical and regulatory purposes.In a case-cohort study among 110 631 Chinese workers first employed 1949-1987 and followed up during 1972-1999, we evaluated BP risk according to benzene exposure level and investigated risk modification by subject (sex, attained age) and exposure-related factors (latency, exposure windows, age at first benzene exposure, coexposure to toluene) using excess relative risk and excess absolute risk models.There were 538 BP cases and 909 benzene-exposed referents. The exposure metric with best model fit was cumulative benzene exposure during a 5-year risk window, followed by a 9-month lag period before BP diagnosis. Estimated excess absolute risk of BP at age 60 increased from 0.5% for subjects in the lowest benzene exposure category (>0 to 10 ppm-years) to 5.0% for those in the highest category (>100 ppm-years) compared with unexposed subjects. Increased risks were apparent at low cumulative exposure levels and for workers who were first exposed at <30 years of age.Our data show a clear association between benzene exposure and BP, beginning at low cumulative benzene exposure levels with no threshold, and with higher risks for workers exposed at younger ages. These findings are important because BP has been linked to a strongly increased development of lymphohaematopoietic malignancies.
科研通智能强力驱动
Strongly Powered by AbleSci AI